The Neuro’s Virtual Integrated Patient Platform (NeuroVIP) is an innovative initiative designed to accelerate the discovery of new treatments for brain and nervous system disorders. Many neurological conditions such as Alzheimer disease, Parkinson disease, and ALS, remain poorly understood and lack effective therapies. NeuroVIP addresses this challenge by bringing together patient data, biological samples, and powerful research tools into a single, open science platform that is accessible to scientists in Canada and worldwide. The platform is built on the combined strengths of five specialized research facilities at The Neuro. The Clinical Research Unit (CRU) recruits patients for clinical trials and research studies. The Clinical Biospecimen Imaging and Genetic (C-BIG) repository collects and stores patient samples and data. The Early Drug Discovery Unit (EDDU) creates patient-derived stem cells and 3D “mini-brains” (organoids) that can be used to test potential treatments. The Neuro Bioinformatics Core (NBC) analyzes complex genetic and molecular data using advanced computing methods, while the Neuro Microscopy Core Facility (NMCF) provides cutting-edge imaging to study brain cells in detail. Together, these resources allow researchers to link clinical information with genetic, cellular, and imaging data in ways that have never been possible before. Importantly, NeuroVIP is committed to open science. All data and materials are shared responsibly with the global research community through secure platforms, while protecting patient privacy. A new patient-facing portal will also allow participants to see how their contributions are helping science and connect them to relevant clinical trials. By partnering with major national and international research networks, NeuroVIP ensures that discoveries made in Canada can benefit patients everywhere. Ultimately, NeuroVIP represents a powerful step forward in precision medicine by helping match the right treatment to the right patient. It empowers researchers, accelerates breakthroughs, and gives patients a direct role in shaping the future of neuroscience.
Partners & Donors
Montreal Neurological Insitute-Hospital (The Neuro)